Ansoxetine
- Level
- Commodity
- Parent
- 51292000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51292003This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3LY71185IQ. European Medicines Agency schedules Ansoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05524MIG. Ansoxetine generally arises in the molecular formula C26H25NO3. The term ANSOXETINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 2, no. 3, 1988, list 28.) ANSOXETINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ansoxetine under HS 29329985 and SITC 51569. As of Q4 2014, ANSOXETINE remains the US FDA Preferred Term for this commodity. Ansoxetine bears US NLM identifiers UMLS ID C2346789 and NCI Concept Code C72702. SMILES: O(C(CCN(C)C)c1ccccc1)c1cc2c(oc(cc2=O)c2ccccc2)cc1.
Same parent
Under 51292000 · 29Activities that produce or sell this
KBLI · 8Inherited from family 51290000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.